| 名称 | WAY-100635 Monomaleate |
| 描述 | WAY-100635 maleate is a selective 5-hydroxytryptamine 1A receptor antagonist with an IC50 value of 0.91 nM and a Ki value of 0.39 nM. It is also a dopamine D4 receptor agonist with pIC50 values of 8.9 and 6.6 for 5-HT1A and α1-adrenergic, respectively. |
| 细胞实验 | Extracellular recordings are made with glass microelectrodes filled with 2 M NaC1 (12 MΩ-15 MΩ). Cells are identified as 5-HT neurons according to the following criteria: biphasic action potentials of 2 msec to 3 msec in duration, slow (0.5 Hz - 2.0 Hz) and regular pattern of discharge. Firing is evoked in the otherwise silent neurons by adding the alpha-l adrenergic agonist phenylephrine (3 μM) to the superfusing ACSF. Baseline activity is recorded for at least 10 minutes before application of the different drugs. The electric signals are fed into a high-input impedance amplifier, an oscilloscope and an electronic ratemeter triggered by individual action potentials connected to an A/D converter and a personal computer. Using dedicated software, the integrated firing rate is recorded, computed and displayed on a chart recorder as consecutive 10-sec samples. The effects of agonists are evaluated by comparing the mean discharge frequency recorded during the 2 minutes that preceded WAY 100635 application with that recorded at the peak of WAY 100635 action (usually 2-5 minutes after the beginning of application). When the agonists are applied in the presence of the antagonist, the effect of the agonist is compared to baseline firing rate and to the frequency recorded during superfusion of the antagonist alone. The antagonist is left to equilibrate for 10 minutes to 25 minutes before retesting of the action of agonists. (Only for Reference) |
| 激酶实验 | Enzyme activity assay: To determine the IC50 values of HM781-36B for kinase inhibition, enzymes of EGFR, HER2, and HER4 are expressed as recombinant proteins in Sf9 insect cells. Enzyme selectivity screening is then performed using a tyrosine kinase assay kit. Briefly, the reactions are performed in 96 well polystyrene round-bottomed plates containing kinase buffer composed of 100 mM HEPES (pH 7.4), 25 mM MgCl2, 10 mM MnCl2 and 250 μM Na3VO4. The reactions are initiated by the addition of 100 ng/assay enzyme, 100 μM ATP, and 10 ng/mL poly(Glu, Tyr). After 1 h of incubation at room temperature, the reactions are terminated by adding 6 mM EDTA solution and then anti-phosphotyrosine antibody, PTK Green Tracer, and FP dilution buffer mixtures. The fluorescence polarization values are then measured after 30 min at room temperature using a Victor3 microplate reader. Finally, the IC50 values were calculated using the following equation: Y = bottom + (top–bottom)/(1 + 10(X-logIC50)). |
| 体外活性 | 在小鼠中,通过静脉给药WAY 100635后,能够选择性结合到脑5-HT1A受体.在小鼠和大鼠体内,WAY 100635（ID50=0.01 mg/kg. s.c）能够阻断8-OH-DPAT诱导的低体温症. |
| 体内活性 | WAY 100635所产生的拮抗作用通过增加5-HT的浓度至300 μM,IC50为0.95 nM。 |
| 存储条件 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
| 溶解度 | Ethanol : 79 mg/mL (146.7 mM)
DMSO : 55 mg/mL (102.11 mM)
|
| 关键字 | 5-HT Receptor | WAY 100635 | WAY 100635 Maleate | WAY-100635 Maleate | WAY-100635 | Dopamine Receptor | WAY100635 Maleate | inhibit | 5-hydroxytryptamine Receptor | Inhibitor | WAY100635 | Serotonin Receptor |
| 相关产品 | Cinchonidine | Oxolinic acid | Citicoline | Cloperastine hydrochloride | Alverine citrate | Dapoxetine hydrochloride | Trazodone hydrochloride | Mianserin hydrochloride | L-DOPA | Fluoxetine hydrochloride | CLOZAPINE N-OXIDE | Octopamine hydrochloride |
| 相关库 | 抑制剂库 | 经典已知活性库 | 已知活性化合物库 | GPCR靶点分子库 | 神经退行性疾病化合物库 | 膜蛋白靶向化合物库 | 疼痛相关化合物库 | 抗代谢疾病化合物库 |
